Preventing implantation failure during IVF comes down to addressing the two sides of the equation: the embryo and the uterine environment. When transfers repeatedly fail, there’s almost always a specific, identifiable reason, whether it’s embryo chromosomal problems, mistimed transfers, a subtle uterine infection, or hormonal levels that are off target. The good news is that most of these factors can be tested for and corrected.
When Implantation Failure Becomes “Recurrent”
Not every failed transfer signals a deeper problem. IVF doesn’t work every time, even under ideal conditions. The European Society of Human Reproduction and Embryology defines recurrent implantation failure (RIF) not by a fixed number of failed transfers but by whether your cumulative predicted chance of success has passed 60% without a positive pregnancy test. In practical terms, this usually means two or three transfers of good-quality embryos without success. At that point, your clinic should start investigating specific causes rather than simply trying again with the same approach.
Start With the Embryo
The single biggest reason embryos fail to implant is that they carry the wrong number of chromosomes. These embryos may look perfectly normal under a microscope but are genetically unable to develop. The rate of chromosomal abnormality climbs steeply with age: roughly 25% of embryos are abnormal in women aged 25 to 30, over 50% after 35, and nearly 90% by age 44.
Preimplantation genetic testing for aneuploidy (PGT-A) screens embryos before transfer and filters out those that won’t implant or would end in miscarriage. Even with genetically normal embryos, age still matters. Live birth rates after transferring a chromosomally normal embryo are about 54% for women under 37 but drop to around 42% for women 38 and older. That gap reflects changes in egg quality and uterine factors that go beyond chromosome count alone.
If you haven’t done PGT-A testing and you’ve had multiple failed transfers, this is typically the first step your clinic will recommend. It won’t create better embryos, but it prevents you from transferring ones that were never going to work.
Check the Timing of Your Transfer
Your uterus has a narrow window, usually about 24 to 48 hours, when the lining is receptive to an embryo. If your transfer happens outside that window, even a perfect embryo won’t implant. The endometrial receptivity analysis (ERA) test measures the activity of 248 genes in a small sample of uterine lining to determine whether your window is earlier or later than average.
In one study of 281 women with recurrent implantation failure, the ERA test found that 65% of them had a displaced receptivity window. When transfers were rescheduled to match each woman’s actual window, the clinical pregnancy rate doubled, jumping from about 25% with standard timing to 50% with personalized timing. The implantation rate showed a similar improvement, rising from 19% to 42%. For women whose window turns out to be shifted, this adjustment can be the difference between repeated failure and a successful pregnancy.
Rule Out Uterine Problems
Structural issues inside the uterus can physically block implantation or disrupt blood flow to the lining. Polyps, fibroids that press into the uterine cavity, scar tissue from prior procedures, and a uterine septum are the most common culprits. Most of these are detectable with a saline ultrasound or hysteroscopy.
Small endometrial polyps under 2 cm don’t always prevent implantation, but they do increase the risk of pregnancy loss. The safest strategy for women with polyps who are about to start a transfer cycle is to remove the polyps first, freeze the embryos, and transfer in a later cycle. Fibroids that bulge into the uterine cavity generally need removal regardless of size, while fibroids embedded in the muscle wall are less likely to interfere unless they’re large enough to distort the cavity’s shape.
Treat Hidden Uterine Infections
Chronic endometritis is a low-grade bacterial infection of the uterine lining that often causes no symptoms at all. It’s diagnosed by finding specific immune cells called plasma cells in a biopsy of the lining. This infection is surprisingly common in women with recurrent implantation failure and is one of the most treatable causes.
When antibiotics successfully clear the infection, the results are striking. One study found that women who responded to antibiotic treatment achieved a 65% clinical pregnancy rate and a 61% live birth rate, compared to just 33% and 13% in women whose infection persisted. A meta-analysis confirmed the pattern: women whose chronic endometritis was cured had four times the implantation rate and nearly seven times the live birth rate of those with ongoing infection. If your clinic hasn’t tested for this after repeated failures, it’s worth asking about.
Get Progesterone Levels Right
Progesterone prepares and maintains the uterine lining for implantation. In frozen embryo transfer cycles, progesterone is given as medication, and the blood level on the day of transfer matters more than most patients realize. Research on transfers of single genetically normal embryos found that the sweet spot is between 10 and 20 ng/mL. Live birth rates were highest (around 70%) at the lower end of that range and dropped progressively as levels climbed: 62% at 15 to 20, 52% at 20 to 30, and just 33% above 40 ng/mL.
Levels above 30 ng/mL clearly harm outcomes and should be avoided. If you’re using vaginal, injectable, or oral progesterone, your clinic can check your serum level a few days before transfer and adjust the dose. This is a simple blood draw that can meaningfully change your chances.
Screen for Blood Clotting and Immune Issues
A small subset of women with recurrent implantation failure have underlying blood clotting disorders (thrombophilias) or immune imbalances that interfere with the early stages of pregnancy. Standard screening includes tests for lupus anticoagulant, anticardiolipin antibodies, and protein C and S activity. On the immune side, some clinics measure vitamin D levels and the balance between two types of immune cells (Th1 and Th2 cells) that influence whether the body accepts or attacks an implanting embryo.
These aren’t first-line tests. They’re most useful after more common causes like embryo quality, timing, and uterine problems have been addressed. When a clotting disorder is found, treatment with blood thinners during the transfer cycle can improve outcomes. Low vitamin D is easy to correct with supplementation and has been linked to better implantation and lower miscarriage rates in women with PCOS.
Fresh vs. Frozen Transfers
The choice between a fresh transfer (in the same cycle as egg retrieval) and a frozen transfer depends on your specific situation. For women with a low predicted chance of success, fresh transfers have shown a meaningful advantage. A large randomized trial found live birth rates of 40% with fresh transfers compared to 32% with frozen, and cumulative rates over one year were 51% versus 44%. The gap likely reflects the fact that freezing and thawing adds a small amount of stress to embryos, which matters more when there are fewer embryos to work with.
For women with a good number of embryos or those who need PGT-A testing, frozen transfers remain the standard approach. Your clinic’s recommendation should factor in your embryo count, whether genetic testing is planned, and whether you need time to address uterine issues before transfer.
Lifestyle Factors That Affect Implantation
Caffeine intake is one of the few lifestyle factors with clear, dose-dependent data in IVF patients. Women consuming more than 50 mg of caffeine per day (roughly half a standard cup of coffee) had nearly four times the odds of not achieving a live birth compared to women who consumed almost none. The current recommendation is to stay under 200 mg per day, but the data suggests that less is better.
Smoking consistently lowers IVF success rates across studies, though the exact dose threshold isn’t well defined. The safest approach is to stop entirely before starting a cycle. Maintaining a healthy weight also matters, as both very low and very high BMI can impair implantation, though the exact cutoffs vary by clinic.
Supplements That May Help Egg Quality
CoQ10 is the supplement with the strongest evidence for improving egg quality, particularly in women over 35. It works by boosting energy production inside egg cells and reducing the kind of oxidative damage that accumulates with age. Studies show it can improve IVF success rates by restoring normal energy metabolism in aging eggs, reducing DNA damage, and lowering rates of egg cell death.
Vitamin D supplementation improves embryo quality in some studies, especially in women with PCOS, where it has been shown to raise ovulation and pregnancy rates while lowering miscarriage risk. Combined vitamin D and vitamin E supplementation has been linked to higher implantation rates in IVF cycles, likely through antioxidant effects. Neither supplement is a substitute for addressing the medical causes of implantation failure, but both are low-risk additions to a broader strategy. Ask your clinic about appropriate doses based on your blood levels.